|
It was reported during a trans ulnar access case, the physician experienced a non-deployment using the cguard prime carotid stent system 135cm.The physician attempted to use a secondary cguard prime carotid stent system 135cm using the trans femoral approach, however the issue persisted.A competitor stent was used to complete the procedure successfully with no reported patient harm.The system was able to be deployed outside of the patients body.
|
|
See additional manufacturer report #s for secondary device used during the same procedure: 3031658894-2026-00060 and uf/importer report # 3032814119-2025-00015.This mdr is being submitted retrospectively as part of capa-us-002-26, identified during a retrospective review conducted under the capa.See related importer report # 3032814119-2025-00016.Device investigation: the device was not returned to inspiremd for investigation, however, production records review confirmed the device met all manufacturing specifications, with no malfunction or nonconformance identified.The procedure was completed using a competitor stent, and no patient harm or adverse clinical outcome was reported.An investigation was initiated to identify the underlying failure mode(s) associated with delivery system deployment complications which may result in high resistance or inability to deploy the stent.Inspiremd's recall (recall no.Z-2330-2026), initiated on may 1, 2026, identified a delivery system issue in the cguard® prime carotid stent system.However, this event occurred prior to the initiation of the recall activities.Capa-027-25 has been initiated to further evaluate similar field-reported performance issues, and complaint trending activities remain ongoing.
|